Promising compound kills range of hard-to-treat cancers
Ratna Vadlamudi, PhD, a professor of obstetrics and gynecology at the Mays Cancer Center, is researching compounds that can target cancer cells to stop their growth.
Ratna Vadlamudi, PhD, a professor of obstetrics and gynecology at the Mays Cancer Center, is researching compounds that can target cancer cells to stop their growth.
The Mays Cancer Center and Evestra Inc., a San Antonio, Texas-based biopharmaceutical company, have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health.
Yasmin Lyons, DO, explains the signs and symptoms of cervical cancer along with screening guidelines.
Ovarian cancer is responsible for more deaths than any other cancers of the female reproductive system and is the fifth leading cause of cancer death.
Jane Mattei, MD, joined Mays Cancer Center as a medical oncologist specializing in melanoma and other skin cancers and Gary Lewis, MD, has started as a radiation oncologist specializing in gynecologic brachytherapy and head and neck cancers.
Researchers from the Mays Cancer Center at UT Health San Antonio presented results of multiple lines of study during the San Antonio Breast Cancer Symposium, operated in conjunction with the American Association of Cancer Research.
“I hope all my patients feel they’ve been listened to with compassion, and I hope I’ve helped them really understand what’s going on with their care.”